|
|
|
|
Lux Biosciences Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for LUVENIQ
-- Acceptance of PIP Is Pre-Requisite for European Approval -- JERSEY CITY, N.J.--(BUSINESS WIRE)--Nov 26, 2008 - Lux Biosciences today announced that the Pediatric Committee of the European Medicines Agency (EMEA) has issued a positive...
|
|
|
Lux Biosciences Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for LUVENIQ
- Lux Biosciences today announced that the Pediatric Committee of the European Medicines Agency (EMEA) has issued a positive opinion on Luxs Pediatric Investigation Plan (PIP) for LUVENIQ (oral formulation of voclosporin), the companys...
|
|
|
Lux Biosciences Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for LUVENIQ
Lux Biosciences today announced that the Pediatric Committee of the European Medicines Agency (EMEA) has issued a positive opinion on Luxs Pediatric Investigation Plan (PIP) for LUVENIQ„ (oral formulation of voclosporin), the...
|
|
|
Lux Biosciences Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for LUVENIQ
JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences today announced that the Pediatric Committee of the European Medicines Agency (EMEA) has issued a positive opinion on Luxs Pediatric Investigation Plan (PIP) for LUVENIQ (oral formulation...
|
|
|
Isotechnika's Partner Receives European Medicines Agency Acceptance of its Pediatric Investigation Plan for Lu
EDMONTON, Nov.26 /CNW/ - Isotechnika Inc. announced today that its partner, Lux Biosciences Inc., received a positive opinion from the Pediatric Committee of the European Medicines Agency (EMEA) regarding their Pediatric Investigation...
|
|
|
Lux Biosciences Announces European Medicines Agency Acceptance of Its Pediatric Investigation
Lux Biosciences today announced that the Pediatric Committee of the European Medicines Agency (EMEA) has issued a positive opinion on Lux's Pediatric Investigation Plan (PIP) for LUVENIQ(TM) (oral formulation of voclosporin), the company's...
|
|
|
Lux Biosciences Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for LUVENIQ
Lux Biosciences Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for LUVENIQ" -- Acceptance of PIP Is Pre-Requisite for European Approval -- JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences today...
|
|
|
Human Immunodeficiency Virus-induced Uveitis: Intraocular and Plasma Human Immunodeficiency Virus-1 RNA Loads
_ Human Immunodeficiency Virus-induced Uveitis: Intraocular and Plasma Human Immunodeficiency Virus-1 RNA Loads.
|
|
|
Melatonin May Save Eyesight In Inflammatory Disease, Study Suggests
ScienceDaily (Nov.23, 2008) Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease. People with uveitis develop sudden redness and pain in their eyes, and their vision rapidly...
|
|
|
Melatonin may save eyesight in inflammatory disease
Buenos Aires, Argentina Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease.The related report by Sande et al., 'Therapeutic Effect of Melatonin in Experimental Uveitis,'...
|
|
|
Melatonin may save eyesight in inflammatory disease
Buenos Aires, Argentina Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease.The related report by Sande et al., 'Therapeutic Effect of Melatonin in Experimental Uveitis,'...
|
|
|
Melatonin may save eyesight in inflammatory disease
Buenos Aires, Argentina - Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease.The related report by Sande et al., 'Therapeutic Effect of Melatonin in Experimental Uveitis,'...
|
|
|
Uveitis and juvenile idiopathic arthritis: A cohort study
88.4% of children with JIA presented with arthritis; uveitis detected in 9.2% during the first ophthalmic exam In additional 11.2% of pts, uveitis developed during the f/u period of up to 15 yrs 11.Uveitis and juvenile idiopathic...
|
|
|
GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males
GARDASIL[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV)...
|
|
|
Adalimumab Decreases Rate of Anterior Uveitis in Ankylosing Spondylitis: Presented at AAO
-- The anti-tumour necrosis factor inhibitor adalimumab appears to effectively inhibit the development of anterior-uveitis episodes in patients with ankylosing spondylitis, according to new research presented here at the American Academy of...
|
|
|
Next-generation calcineurin inhibitor in pivotal trials for
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo Enrollment has been completed in a series of phase III studies investigating voclosporin (Lumeniq, Lux Biosciences) as a...
|
|
|
Next-generation calcineurin inhibitor in pivotal trials for noninfectious uveitis
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo Enrollment has been completed in a series of phase III studies investigating voclosporin (Lumeniq, Lux Biosciences) as a...
|
|
|
AAO: Next-generation calcineurin inhibitor in pivotal trials for
Source: Ophthalmology Times Meeting E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License |Discuss On Sermo Enrollment has been completed in a series of phase III studies investigating voclosporin (Lumeniq, Lux Biosciences) as a...
|
|
|
Outcome of Phacoemulsification in Patients with Uveitis
Elgohary MA et al.- The majority of patients with uveitis achieve improvement of their visual acuity after phacoemulsification but an increasing rate of doubling of the visual angle occurs in patients with pre-existent macular or optic...
|
|
|
Mycophenolate Mofetil for the Treatment of Uveitis
Current Allergy and Asthma Reports, 10/23/08 Current Allergy and Asthma Reports, 10/27/08 Mycophenolate Mofetil for the Treatment of Uveitis.
|
|
|
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Tre
TAMPA, Fla., Nov.3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding...
|
|
|
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Tre
TAMPA, Fla., Nov.3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding...
|
|
|
Unilateral Granulomatous Post-Streptococcal Uveitis with Elevated Tension
Besada E et al.- Unilateral, granulomatous anterior uveitis may be a variant manifestation of post-streptococcal uveitis. The IOP elevation in these cases may result secondary to concurrent trabeculitis. --- UVEITIS TOP ARTICLES...
|
|
|
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Tre
TAMPA, Fla., Nov.3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding...
|
|
|
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Tre
TAMPA, Fla., Nov.3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding...
|
